Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Published:2011-11-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rees Karen¹,Stowe Rebecca²,Patel Smitaa²,Ives Natalie²,Breen Kieran³,Clarke Carl E⁴,Ben-Shlomo Yoav⁵

Affiliation:

1. Warwick Medical School, University of Warwick; Division of Health Sciences; Coventry UK CV4 7AL

2. University of Birmingham; Birmingham Clinical Trials Unit; Edgbaston Birmingham UK B15 2TT

3. Parkinson's Disease Society; Research and Development Directorate; 215 Vauxhall Bridge Road London UK SW1V 1EJ

4. College of Medicine and Dental Sciences; School of Clinical and Experimental Medicine; University of Birmingham Edgbaston Birmingham West Midlands UK B18 7QH

5. Canynge Hall; Dept of Social Medicine; Whiteladies Road Bristol UK BS8 2PR

Publisher

Wiley

Subject

Pharmacology (medical)

Reference55 articles.

1. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease;Bornebroek;Neuroepidemiology,2007

2. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study;Bower-JH;Neurology,2006

3. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease;Chen;Archives of Neurology,2003

4. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease;Chen;Annals of Neurology,2005

5. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case control study;Driver;British Medical Journal,2011

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis;Scientific Reports;2024-08-24

2. Update: Protective and risk factors for Parkinson disease;Parkinsonism & Related Disorders;2024-08

3. TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition;Molecular Neurobiology;2024-07-23

4. Epidemiology of Parkinson’s Disease: An Update;Current Neurology and Neuroscience Reports;2024-04-20

5. Statistical integration of multi-omics and drug screening data from cell lines;PLOS Computational Biology;2024-01-31